Skip to content

Clinical trials

Phase 2/3 Heart Defects, Congenital trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Defects, Congenital Phase: Phase 2/3 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20162
20171
20191
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status3
Enrolling by invitation1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ethicare GmbH2
Abbott1
Boston Children's Hospital1
Children's Hospital Medical Center, Cincinnati1
Competence Network for Congenital Heart Defects1
Ellen Spurrier1
Instituto Nacional de Cardiologia Ignacio Chavez1
Medical College of Wisconsin1
University of California, Los Angeles1
University of Utah1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Defects, Congenital12
Heart Failure3
Acute Kidney Injury1
Bronchopulmonary Dysplasia1
Cardiomyopathy, Dilated1
Hypoxia1
Infections1
Neurodevelopmental Disorders1
Premature Birth1
Reperfusion Injury1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.